Artificial intelligence for modelling infectious disease epidemics

Abstract

Infectious disease threats to individual and public health are numerous, varied and frequently unexpected. Artificial intelligence (AI) and related technologies, which are already supporting human decision making in economics, medicine and social science, have the potential to transform the scope and power of infectious disease epidemiology. Here we consider the application to infectious disease modelling of AI systems that combine machine learning, computational statistics, information retrieval and data science. We first outline how recent advances in AI can accelerate breakthroughs in answering key epidemiological questions and we discuss specific AI methods that can be applied to routinely collected infectious disease surveillance data. Second, we elaborate on the social context of AI for infectious disease epidemiology, including issues such as explainability, safety, accountability and ethics. Finally, we summarize some limitations of AI applications in this field and provide recommendations for how infectious disease epidemiology can harness most effectively current and future developments in AI.

 

Image source: warm data, beachmobjellies, flickr, CC BY-SA 2.0 (as of 8/19/2025), No Changes

Authors

Moritz U. G. Kraemer

Joseph L.-H. Tsui

Serina Y. Chang

Spyros Lytras

Mark P. Khurana

Samantha Vanderslott

Sumali Bajaj

Neil Scheidwasser

Jacob Liam Curran-Sebastian

Elizaveta Semenova

Mengyan Zhang

H. Juliette T. Unwin

Oliver J. Watson

Cathal Mills

Abhishek Dasgupta

Luca Ferretti

Samuel V. Scarpino

Etien Koua

Oliver Morgan

Houriiyah Tegally

Ulrich Paquet

Loukas Moutsianas

Christophe Fraser

Neil M. Ferguson

Eric J. Topol

David A. Duchêne

Tanja Stadler

Patricia Kingori

Michael J. Parker

Francesca Dominici

Nigel Shadbolt

Marc A. Suchard

Oliver Ratmann

Seth Flaxman

Edward C. Holmes

Manuel Gomez-Rodriguez

Bernhard Schölkopf

Christl A. Donnelly

Oliver G. Pybus

Simon Cauchemez

Samir Bhatt

In Development

Currently in development, launching early 2021.